Divya Dhankhar has been appointed as the Director of Global Digital Innovation & AI at Gilead Sciences, marking a strategic move to enhance the company's digital capabilities.
In her new role, Dhankhar will be responsible for leading initiatives that integrate artificial intelligence and digital innovation into Gilead's global operations, aiming to improve customer engagement. She previously held a significant position at Lundbeck, where she directed Next Best Experience (NBX) initiatives, utilizing AI to refine customer interactions and optimize omnichannel strategies.
Dhankhar's experience also includes several leadership roles at Cognizant, where she collaborated with major life sciences companies like AbbVie on various digital transformation projects. Her expertise encompasses commercial operations, sales analytics, and data-driven decision-making, all crucial for enhancing customer-centric innovation in the pharmaceutical sector.
This appointment highlights Gilead Sciences' commitment to advancing its digital transformation efforts, particularly in leveraging AI to boost commercial effectiveness and foster deeper customer relationships. As the industry increasingly relies on technology, Dhankhar's leadership could be pivotal in driving Gilead's innovative strategies forward.